|
"huang shiu feng"的相关文件
显示项目 16-25 / 42 (共5页)
<< < 1 2 3 4 5 > >>
每页显示[10|25|50]项目
| 國立成功大學 |
2014-01-20 |
Impact of ROS1, ALK, and/or MET expression level on the therapeutic efficacy of GEMOX with and without cetuximab in ABTC: A post hoc analysis of a randomized phase II trial
|
Chiang, Nai-Jung; Hsu, Chiun; Chen, Jen-Shi; Tsou, Hiso-Hui; Chao, Yee; Shan, Yang-Shen; Huang, Shiu-Feng; Chiu, Chang-Fang; Lee, Kuan-Der; Chen, Li-Tzong |
| 國立成功大學 |
2013-05-20 |
KRAS mutation status-stratified randomized phase II trial of GEMOX with and without cetuximab in advanced biliary tract cancer (ABTC): The TCOG T1210 trial
|
Chen, Li-Tzong; Chen, Jen-Shi; Chao, Yee; Tsai, Chang-Sung; Shan, Yan-Shen; Hsu, Chiun; Huang, Shiu-Feng; Tsou, Hsiao-Hui; Lee, Kuan-Der; Chiu, Chang-Fang; Rau, Kun-Ming; Ho, Ching-Liang; Yu, Ming-Sun |
| 國立臺灣大學 |
2013 |
Characterization of Neuroblastic Tumors Using F-18-FDOPA PET
|
Lu, Meng-Yao; Liu, Yen-Lin; Chang, Hsiu-Hao; Jou, Shiann-Tarng; Yang, Yung-Li; Lin, Kai-Hsin; Lin, Dong-Tsamn; Lee, Ya-Ling; Lee, Hsinyu; Wu, Pei-Yi; Luo, Tsai-Yueh; Shen, Lie-Hang; Huang, Shiu-Feng; Liao, Yung-Feng; Hsu, Wen-Ming; Tzen, Kai-Yuan; 林東燦; 許文明; 曾凱元; 周獻堂; 盧孟佑; 張修豪; 林凱信; 楊永立; 李雅玲 |
| 國立臺灣大學 |
2011 |
A Cullin3-Klhl20 Ubiquitin Ligase-Dependent Pathway Targets Pml to Potentiate Hif-1 Signaling and Prostate Cancer Progression
|
袁維謙; 李玉如; 黃秀芬; 林裕敏; 陳姿穎; 鍾向晴; 陳忻怡; 陳瑞華; 施修明; 周玉山; 陳俊豪; 蒲永孝; YUAN, WEI-CHIEN; LEE, YU-RU; HUANG, SHIU-FENG; LIN, YU-MIN; CHEN, TZU-YIN; CHUNG, HSIANG-CHING; CHEN, HSIN-YI; CHEN, RUEY-HWA; SHIH, HSIU-MING; JOU, YUH-SHAN; CHEN, CHUN-HAU; PU, YEONG-SHIAU |
| 國立臺灣大學 |
2010 |
Notch1 Expression Predicts an Unfavorable Prognosis and Serves as a Therapeutic Target of Patients with Neuroblastoma
|
張修豪; 李心予; 胡明寬; 曹伯年; 阮雪芬; 黃敏銓; 許文明; 王柏堅; 鄭永銘; 林凱信; 黃秀芬; 蔡有光; 謝豐舟; 廖永豐; CHANG, HSIU-HAO; LEE, HSIN-YU; HU, MING-KUAN; TSAO, PO-NIEN; JUAN, HSUEH-FEN; HUANG, MIN-CHUAN; HSU, WEN-MING; WANG, BO-JENG; JENG, YUNG-MING; LIN, KAI-HSIN; HUANG, SHIU-FENG; TSAY, YEOU-GUANG; HSIEH, FON-JOU; LIAO, YUNG-FENG |
| 國立臺灣大學 |
2010 |
Sirolimus-Induced Signaling Modifications in Kaposi's Sarcoma with Resolution in a Liver Transplant Recipient
|
何承懋; 黃秀芬; 胡瑞恆; 何明志; 吳耀銘; 李伯皇; HO, CHENG-MAW; HUANG, SHIU-FENG; HU, REY-HENG; HO, MING-CHIH; WU, YAO-MING; LEE, PO-HUANG |
| 國立臺灣大學 |
2010 |
Notch1 Expression Predicts an Unfavorable Prognosis and Serves as a Therapeutic Target of Patients with Neuroblastoma
|
Chang, Hsiu-Hao; Lee, Hsinyu; Hu, Ming-Kuan; Tsao, Po-Nien; Juan, Hsueh-Fen; Huang, Min-Chuan; Shih, Yu-Yin; Wang, Bo-Jeng; Jeng, Yung-Ming; Chang, Christina Ling; Huang, Shiu-Feng; Tsay, Yeou-Guang; Hsieh, Fon-Jou; Lin, Kai-Hsin; Hsu, Wen-Ming; Liao, Yung-Feng |
| 國立臺灣大學 |
2009 |
Signaling Modification in Kaposi's Sarcoma by Sirolimus in a Liver Recipient: Evidence of Malignancy Cured by Immunosuppressant
|
黃秀芬; 吳耀銘; 何明志; 胡瑞恆; 李伯皇; HUANG, SHIU-FENG; WU, YAO-MING; HO, MING- CHIH; HU, REY-HENG; LEE, PO-HUANG |
| 國立臺灣大學 |
2008 |
Decreased Expression of Uk114 Is Related to the Differentiation Status of Human Hepatocellular Carcinoma
|
黃秀芬; 胡承波; 周嘉揚; 許金玉; 陳炯東; 張仲明; 陳孟良; HUANG, SHIU-FENG; HU, CHENG-PO; CHAU, GAR -YANG; SHEW, JIN-YUH; CHEN, CHIUNG-TONG; CHANG, CHUNG-MING; CHEN, MONG-LIANG |
| 國立臺灣大學 |
2007 |
Met Amplification Occurs with or without T790m Mutations in Egfr Mutant Lung Tumors with Acquired Resistance to Gefitinib or Erlotinib
|
施金元; 張文誠; 余忠仁; 黃秀芬; 楊泮池; 楊志新; SHIH, JIN-YUAN; CHANG, WEN-CHENG; YU, CHONG-JEN; HUANG, SHIU-FENG; YANG, PAN-CHYR; YANG, CHIH-HSIN |
显示项目 16-25 / 42 (共5页)
<< < 1 2 3 4 5 > >>
每页显示[10|25|50]项目
|
